Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Progesterone Vaginal Rings in Postmenopausal Women
NCT02092571Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of progesterone in menopause (2 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Area Under the Curve to the last measurable concentration (baseline-adjusted) at 16 weeks, Area Under the Curve to infinity (baseline-adjusted) at 16 weeks and 1 more. Started Feb 2014; status: completed.
02
Drugs
progesterone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT02092571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092571.